ONO-7436 Phase II Study in Japan

NCT00212602 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Tumor

Interventions

DRUG: ONO-7436

Sponsor

Ono Pharmaceutical Co., Ltd.